DrugDashboards

Ofloxacin

Ofloxacin Ophthalmic Solution USP, 0.3% · OFLOXACIN 3 mg/mL · Solution/ Drops · Ophthalmic · Caplin Steriles Limited

NDC 65145-0141-01 · 5 mL in 1 BOTTLE, DROPPER · ANDA · View full market →

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately. The price is down 23% over the past year, to $1.27 per mL. Put together: worth watching — several of the pressures that precede supply trouble are present at once.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$1.00$2.00May 2025Sep 2026$1.27
17 price points · per MLSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$15.00
Reported to Texas DSHS · 2026 annual filing · Caplin Steriles USA Inc

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$479
25 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

28Elevated risk

The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.

  • 2 active manufacturers+20
  • price down 22% year over year+8

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for ofloxacin (other) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA217904
TE code
AT
Approval date
Apr 12, 2024
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Ofloxacin Ophthalmic Solution USP, 0.3% (Solution/ Drops)

LabelerStrengthFirst seenLast seen
Caplin Steriles LimitedOFLOXACIN 3 mg/mLJul 15, 2026Sep 3, 2026
SOLA Pharmaceuticals, LLCOFLOXACIN 3 mg/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Ofloxacin — NDC 65145-0141-01," retrieved September 3, 2026, https://drugdashboards.com/drug/65145014101.

Free to cite with attribution — see how the data is put together.